Accenture Makes Strategic Investment in ixlayer to Expand Access to Virtual Diagnostic Health Testing

NEW YORK; Aug. 24, 2021 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in ixlayer, a provider of technology-based solutions for diagnostic testing. The company’s telehealth platform allows players across the healthcare ecosystem to offer convenient and scalable health testing in a virtual environment. 

Comments

Popular posts from this blog

Add Custom Field in Output of Standard Report of ME2N

Accenture to Strengthen Oracle Capabilities in the Middle East with AppsPro Acquisition

Accenture and Mujin Collaborate to Help Clients Accelerate Digital Transformation in the Logistics Industry